Artivion AORT Products — Total revenues
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Artivion in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Artivion’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Artivion's products — total revenues.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Artivion's products — total revenues?
- Artivion (AORT) reported products — total revenues of $91.44M in Q1 2026.
- How has Artivion's products — total revenues changed year-over-year?
- Artivion's products — total revenues increased by 16.0% year-over-year, from $78.8M to $91.44M.
- What is the long-term trend for Artivion's products — total revenues?
- Over 4 years (2021 to 2025), Artivion's products — total revenues has grown at a 11.8% compound annual growth rate (CAGR), from $221.6M to $345.83M.
- What does products — total revenues mean?
- This metric represents the aggregate gross revenue generated from the sale of medical devices and surgical products within the company's primary product segment. It reflects the total market demand for the company's aortic-centric portfolio, including heart valves, surgical adhesives, and related medical technologies. This figure serves as a key indicator of the company's top-line growth and market penetration in the cardiac and vascular surgical space.